Abstract
Doxorubicin plus ketoconazole has exhibited significant activity in patients with advanced prostate cancer. However, overall and cardiac-specific toxicity was reported to be high. Mitoxantrone has activity similar to that of doxorubicin, is less cardiotoxic, and is widely used to treat prostate cancer. The current study sought to evaluate the toxicity and activity of mitoxantrone plus ketoconazole in a cohort of patients with hormone-refractory prostate cancer. Progression after medical or surgical castration and, for those patients receiving antiandrogens, progression after withdrawal was required, as was objective evidence of metastasis, castrate levels of testosterone, an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2, and intact cardiac function. After enrollment onto a multicenter local consortium study, subjects were treated with mitoxantrone at a dose of 12 mg/m2 intravenously every 3 weeks plus continuous oral ketoconazole at a dose of 400 mg 3 times daily and ascorbic acid at a dose of 250 mg. Replacement doses of hydrocortisone were given. For 40 enrolled subjects, the median prostate-specific antigen and ECOG performance status were 68 and 1, respectively, 53% had Gleason scores of 8 to 10, an...Continue Reading
References
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·G R Fisher, L H Patterson
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L TrumpV C Jordan
Mar 1, 1989·Controlled Clinical Trials·R Simon
Jan 1, 1989·The Journal of Urology·T EichenbergerA Keating
Feb 1, 1988·Urology·D E JohnsonD Tenney
Feb 1, 1986·British Journal of Urology·G WilliamsS R Bloom
Nov 1, 1982·Archives of Internal Medicine·A PontD A Stevens
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SellaC J Logothetis
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F TannockK C Murphy
Apr 1, 1997·The Journal of Urology·E J SmallD Apodaca
Sep 19, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G R HudesC McAleer
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G J BubleyG Wilding
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W KantoffN J Vogelzang
Jul 20, 2002·The Journal of Urology·Katherine A HarrisEric J Small
Jun 6, 2003·Cancer Treatment Reviews·Cynthia L MartelPrimo N Lara
Jun 26, 2003·International Journal of Urology : Official Journal of the Japanese Urological Association·Karel OdrazkaEva Simakova
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J SmallNicholas J Vogelzang
Apr 15, 2004·European Urology·Simon Wilkinson, Gerald Chodak
Jun 26, 2004·Oncology·J M FerreroJ Amiel
Jul 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William L DahutWilliam D Figg
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Nov 19, 2004·European Urology·Giuseppe Di LorenzoSabino De Placido
Dec 23, 2004·Anti-cancer Drugs·B NeriG Nicita
Jan 22, 2005·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Feb 16, 2005·The Journal of Urology·William D FiggWilliam L Dahut
Citations
Aug 21, 2012·Asian Journal of Andrology·Guo-Wen LinChun-Guang Ma
Aug 3, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Chung-Lin WangSheng-Nan Wu
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irina VeytsmanTito Fojo
Feb 14, 2013·Cancer Investigation·Robert J AmatoMika Stepankiw
Apr 20, 2010·The Journal of Urology·William D FiggWilliam L Dahut
Nov 21, 2007·Bioorganic & Medicinal Chemistry Letters·Mariano A E Pinto-Bazurco MendietaRolf W Hartmann
Jun 5, 2007·Bioorganic & Medicinal Chemistry·Robert D Bruno, Vincent C O Njar
Aug 23, 2008·Archiv der Pharmazie·Mariano A E Pinto-Bazurco MendietaRolf W Hartmann
May 4, 2010·ChemMedChem·Qingzhong HuRolf W Hartmann
Jul 11, 2019·Oncology Letters·Chun-Te LuYu-Ping Hsiao
Aug 5, 2008·Journal of Medicinal Chemistry·Mariano A E Pinto-Bazurco MendietaRolf W Hartmann
Jun 24, 2010·Journal of Medicinal Chemistry·Silvia GobbiAlessandra Bisi
Aug 6, 2010·Journal of Medicinal Chemistry·Qingzhong HuRolf W Hartmann